Quarterly report · Q3
6323.TEDINET S100SLJI
Period2023-03-01 → 2023-11-30
Filed2024-01-15
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 36
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥65.2bn | 2023-03-01 → 2023-11-30 | Cons. | Net sales |
| Revenue | ¥94.5bn | 2022-03-01 → 2023-02-28 | Cons. | Net sales (5-year summary) |
| Revenue | ¥71.4bn | 2022-03-01 → 2022-11-30 | Cons. | Net sales |
| Operating income | ¥15.8bn | 2023-03-01 → 2023-11-30 | Cons. | Operating income |
| Operating income | ¥17.7bn | 2022-03-01 → 2022-11-30 | Cons. | Operating income |
| Ordinary income | ¥21.3bn | 2023-03-01 → 2023-11-30 | Cons. | Ordinary income |
| Ordinary income | ¥30.3bn | 2022-03-01 → 2023-02-28 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥26.7bn | 2022-03-01 → 2022-11-30 | Cons. | Ordinary income |
| Profit before tax | ¥21.3bn | 2023-03-01 → 2023-11-30 | Cons. | Income before income taxes |
| Profit before tax | ¥26.7bn | 2022-03-01 → 2022-11-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥15.5bn | 2023-03-01 → 2023-11-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥21.4bn | 2022-03-01 → 2023-02-28 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥19.7bn | 2022-03-01 → 2022-11-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥15.9bn | 2023-03-01 → 2023-11-30 | Cons. | Profit loss |
| Net income | ¥20.6bn | 2022-03-01 → 2022-11-30 | Cons. | Profit loss |
| Total assets | ¥153.6bn | at 2023-11-30 | Cons. | Assets |
| Total assets | ¥126.5bn | at 2023-02-28 | Cons. | Assets |
| Total assets | ¥126.7bn | at 2022-11-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥56.6bn | at 2023-11-30 | Cons. | Liabilities |
| Total liabilities | ¥51.7bn | at 2023-02-28 | Cons. | Liabilities |
| Net assets / equity | ¥97.0bn | at 2023-11-30 | Cons. | Net assets |
| Net assets / equity | ¥74.8bn | at 2023-02-28 | Cons. | Net assets |
| Net assets / equity | ¥74.4bn | at 2022-11-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥36.7bn | at 2023-11-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥28.3bn | at 2023-02-28 | Cons. | Cash and deposits |
| EPS (basic) | ¥879.05 | 2023-03-01 → 2023-11-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥320.81 | 2023-09-01 → 2023-11-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥1,237.42 | 2022-03-01 → 2023-02-28 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥1,138.05 | 2022-03-01 → 2022-11-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥422.44 | 2022-09-01 → 2022-11-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥877.43 | 2023-03-01 → 2023-11-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥1,235.1 | 2022-03-01 → 2023-02-28 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥1,135.91 | 2022-03-01 → 2022-11-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 58.3% | at 2023-11-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 53.9% | at 2023-02-28 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 54.0% | at 2022-11-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 28
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2023-03-01 → 2023-11-30 | −¥6m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-03-01 → 2023-11-30 | −¥6m |
| Reconciling Itemsreconciling | segment profit | 2023-03-01 → 2023-11-30 | −¥432m |
| jpcrp040300-q3r_E02328-000Life Sciencereportable segment | revenue | 2023-03-01 → 2023-11-30 | ¥300m |
| jpcrp040300-q3r_E02328-000Life Sciencereportable segment | revenue external | 2023-03-01 → 2023-11-30 | ¥300m |
| jpcrp040300-q3r_E02328-000Life Sciencereportable segment | segment profit | 2023-03-01 → 2023-11-30 | −¥115m |
| jpcrp040300-q3r_E02328-000Semiconductor And Liquid Crystalreportable segment | revenue | 2023-03-01 → 2023-11-30 | ¥64.9bn |
| jpcrp040300-q3r_E02328-000Semiconductor And Liquid Crystalreportable segment | revenue external | 2023-03-01 → 2023-11-30 | ¥64.9bn |
| jpcrp040300-q3r_E02328-000Semiconductor And Liquid Crystalreportable segment | revenue intersegment | 2023-03-01 → 2023-11-30 | ¥6m |
| jpcrp040300-q3r_E02328-000Semiconductor And Liquid Crystalreportable segment | segment profit | 2023-03-01 → 2023-11-30 | ¥16.3bn |
| —segment total | revenue | 2023-03-01 → 2023-11-30 | ¥65.2bn |
| —segment total | revenue external | 2023-03-01 → 2023-11-30 | ¥65.2bn |
| —segment total | revenue intersegment | 2023-03-01 → 2023-11-30 | ¥6m |
| —segment total | segment profit | 2023-03-01 → 2023-11-30 | ¥16.2bn |
| Reconciling Itemsreconciling | revenue | 2022-03-01 → 2022-11-30 | −¥14m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-03-01 → 2022-11-30 | −¥14m |
| Reconciling Itemsreconciling | segment profit | 2022-03-01 → 2022-11-30 | −¥495m |
| jpcrp040300-q3r_E02328-000Life Sciencereportable segment | revenue | 2022-03-01 → 2022-11-30 | ¥248m |
| jpcrp040300-q3r_E02328-000Life Sciencereportable segment | revenue external | 2022-03-01 → 2022-11-30 | ¥248m |
| jpcrp040300-q3r_E02328-000Life Sciencereportable segment | segment profit | 2022-03-01 → 2022-11-30 | −¥116m |
| jpcrp040300-q3r_E02328-000Semiconductor And Liquid Crystalreportable segment | revenue | 2022-03-01 → 2022-11-30 | ¥71.1bn |
| jpcrp040300-q3r_E02328-000Semiconductor And Liquid Crystalreportable segment | revenue external | 2022-03-01 → 2022-11-30 | ¥71.1bn |
| jpcrp040300-q3r_E02328-000Semiconductor And Liquid Crystalreportable segment | revenue intersegment | 2022-03-01 → 2022-11-30 | ¥14m |
| jpcrp040300-q3r_E02328-000Semiconductor And Liquid Crystalreportable segment | segment profit | 2022-03-01 → 2022-11-30 | ¥18.4bn |
| —segment total | revenue | 2022-03-01 → 2022-11-30 | ¥71.4bn |
| —segment total | revenue external | 2022-03-01 → 2022-11-30 | ¥71.4bn |
| —segment total | revenue intersegment | 2022-03-01 → 2022-11-30 | ¥14m |
| —segment total | segment profit | 2022-03-01 → 2022-11-30 | ¥18.2bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 357
| Item | Context | Value | Unit |
|---|---|---|---|
| Operating income | Prior1YTDDuration_ReconcilingItemsMember | -495000000 | JPY |
| Operating income | Prior1YTDDuration | 17739000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q3r_E02328-000SemiconductorAndLiquidCrystalReportableSegmentsMember | 64861000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q3r_E02328-000LifeScienceReportableSegmentsMember | 300000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReportableSegmentsMember | 65162000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | CurrentYTDDuration | 65162000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q3r_E02328-000SemiconductorAndLiquidCrystalReportableSegmentsMember | 6000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q3r_E02328-000LifeScienceReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_ReportableSegmentsMember | 6000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_ReconcilingItemsMember | -6000000 | JPY |
| Transactions with other segments | CurrentYTDDuration | － | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q3r_E02328-000SemiconductorAndLiquidCrystalReportableSegmentsMember | 64867000000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q3r_E02328-000LifeScienceReportableSegmentsMember | 300000000 | JPY |
| Net sales | CurrentYTDDuration_ReportableSegmentsMember | 65168000000 | JPY |
| Net sales | CurrentYTDDuration_ReconcilingItemsMember | -6000000 | JPY |
| Net sales | CurrentYTDDuration | 65162000000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q3r_E02328-000SemiconductorAndLiquidCrystalReportableSegmentsMember | 16311000000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q3r_E02328-000LifeScienceReportableSegmentsMember | -115000000 | JPY |
| Operating income | CurrentYTDDuration_ReportableSegmentsMember | 16195000000 | JPY |
| Operating income | CurrentYTDDuration_ReconcilingItemsMember | -432000000 | JPY |
| Operating income | CurrentYTDDuration | 15763000000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)四半期報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の４の７第１項 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)中国財務局長 | |
| Filing date cover page | FilingDateInstant | 2024-01-15 | |
| Quarterly accounting period cover page | FilingDateInstant | Original text (Japanese)第39期第３四半期（自 2023年９月１日 至 2023年11月30日） | |
| Company name cover page | FilingDateInstant | Original text (Japanese)ローツェ株式会社 | |
| Company name in english cover page | FilingDateInstant | RORZE CORPORATION | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表取締役社長 藤代 祥之 | |
| Address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)広島県福山市神辺町字道上1588番地の２ | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)(084)960－0001(代表) | |
| Name of contact person address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)管理部長 伊勢村 英一 | |
| Nearest place of contact cover page | FilingDateInstant | Original text (Japanese)広島県福山市神辺町字道上1588番地の２ | |
| Telephone number nearest place of contact cover page | FilingDateInstant | Original text (Japanese)(084)960－0001(代表) | |
| Name of contact person nearest place of contact cover page | FilingDateInstant | Original text (Japanese)管理部長 伊勢村 英一 | |
| Place for public inspection cover page (text) | FilingDateInstant | Text · Plus | |
| Edinet code | FilingDateInstant | E02328 | |
| Fund code | FilingDateInstant | － | |
| Security code | FilingDateInstant | 63230 | |
| Filer name in japanese | FilingDateInstant | Original text (Japanese)ローツェ株式会社 | |
| Filer name in english | FilingDateInstant | RORZE CORPORATION | |
| Fund name in japanese | FilingDateInstant | － | |
| Fund name in english | FilingDateInstant | － | |
| Cabinet office ordinance | FilingDateInstant | Original text (Japanese)企業内容等の開示に関する内閣府令 | |
| Document type | FilingDateInstant | Original text (Japanese)第四号の三様式 | |
| Accounting standards | FilingDateInstant | Japan GAAP | |
| Whether consolidated financial statements are prepared | FilingDateInstant | true | |
| Industry code when consolidated financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | CTE | |
| Industry code when financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | － |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |